IP Library Assignment 067953/0105
Patent Assignment
Reel/Frame 067953/0105

Security Interest

Recorded: 2024-07-10 Pages: 8
Assignor
Assignee
HCR REDHILL SPV, LLC, AS SUCCESSOR ADMINISTRATIVE AGENT
C/O HEALTHCARE ROYALTY, 300 ATLANTIC STREET, SUITE 600, STAMFORD, CONNECTICUT, 06901
Covered Properties (9)
Polymer Conjugates of Opioid Antagonists
Patent: 7,056,500 →
Application: 10/274,296 →
Publication: US 2003/0124086
Chemically Modified Small Molecules
Patent: 7,786,133 →
Application: 11/015,196 →
Publication: US 2005/0136031
Chemically Modified Small Molecules
Patent: 8,067,431 →
Application: 12/710,167 →
Publication: US 2010/0210676
Chemically Modified Small Molecules
Patent: 8,034,825 →
Application: 12/822,935 →
Publication: US 2010/0305147
Crystalline Naloxol-Peg Conjugate
Patent: 9,012,469 →
Application: 13/823,953 →
Publication: US 2015/0038524
Chemically Modified Small Molecules
Patent: 9,388,104 →
Application: 14/248,245 →
Publication: US 2014/0303403
Crystalline Naloxol-Peg Conjugate
Patent: 9,149,539 →
Application: 14/645,347 →
Publication: US 2015/0283257
Chemically Modified Small Molecules
Application: 16/020,773 →
Publication: US 2019/0099363
Methods of Preparing a Monodisperse Oligo(Ethylene Glycol) Reagent Composition
Application: 17/409,653 →
Publication: US 2021/0393513
Related Assignments (19)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 18, 2005
From: BENTLEY, MICHAEL DAVID; ROBERTS, MICHAEL JAMES; SHEN, XIAOMING; CHENG, LIN
To: NEKTAR THERAPEUTICS AL, CORPORATION
Reel/Frame 016646/0844 →
Assignment of Assignor's Interest Dec 5, 2006
From: BENTLEY, MICHAEL D.; VIEGAS, TACEY X.; GOODIN, RICHARD R.; ZHAO, XUAN
To: NEKTAR THERAPEUTICS AL, CORPORATION
Reel/Frame 018607/0341 →
Merger Aug 31, 2009
From: NEKTAR THERAPEUTICS AL, CORPORATION
To: NEKTAR THERAPEUTICS
Reel/Frame 023196/0394 →
Grant of Security Interest Jul 17, 2012
From: NEKTAR THERAPEUTICS
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 028571/0141 →
Partial Release of Patents Mar 11, 2013
From: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: NEKTAR THERAPEUTICS
Reel/Frame 029964/0920 →
Assignment of Assignor's Interest Aug 12, 2013
From: APTUIT, INC
To: NEKTAR THERAPEUTICS
Reel/Frame 030989/0755 →
Assignment of Assignor's Interest Aug 12, 2013
From: NEKTAR THERAPEUTICS
To: ASTRAZENECA AB
Reel/Frame 030989/0679 →
Assignment of Assignor's Interest Aug 12, 2013
From: ASLUND, BENGT LEONARD; AURELL, CARL-JOHAN; BOHLIN, MARTIN HANS; YMEN, BO INGVAR
To: ASTRAZENECA AB
Reel/Frame 030989/0395 →
Assignment of Assignor's Interest Aug 12, 2013
From: HEALY, ERIC THOMAS; JENSEN, DAVID RICHARD
To: NEKTAR THERAPEUTICS
Reel/Frame 030989/0492 →
Assignment of Assignor's Interest Aug 12, 2013
From: JONAITIS, DAVID THOMAS; PARENT, STEPHAN
To: APTUIT, INC
Reel/Frame 030989/0549 →
Assignment of Assignor's Interest Aug 12, 2013
From: ASTRAZENECA AB
To: NEKTAR THERAPEUTICS
Reel/Frame 030989/0606 →
Grant of Security Interest in United States Patents Oct 6, 2015
From: NEKTAR THERAPEUTICS
To: TC LENDING, LLC, AS COLLATERAL AGENT
Reel/Frame 036796/0562 →
Release of Security Interest Recorded at Reel 28571, Frame 0141 Oct 14, 2015
From: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: NEKTAR THERAPEUTICS
Reel/Frame 036866/0700 →
Assignment of Assignor's Interest Jul 21, 2016
From: BENTLEY, MICHAEL D.; VIEGAS, TACEY X.; GOODIN, RICHARD R.; CHENG, LIN
To: NEKTAR THERAPEUTICS
Reel/Frame 039428/0109 →
Security Interest Oct 8, 2018
From: NEKTAR THERAPEUTICS
To: TC LENDING, LLC, AS COLLATERAL AGENT
Reel/Frame 047095/0939 →
Security Interest Feb 24, 2020
From: REDHILL BIOPHARMA INC.
To: HCR COLLATERAL MANAGEMENT, LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 051909/0460 →
Release of Security Interest Apr 17, 2020
From: TC LENDING, LLC, AS COLLATERAL AGENT
To: NEKTAR THERAPEUTICS
Reel/Frame 053180/0009 →
Assignment of Assignor's Interest Aug 21, 2020
From: LECHUGA-BALLESTEROS, DAVID
To: NEKTAR THERAPEUTICS
Reel/Frame 053557/0568 →
Release of Security Interest Jul 19, 2024
From: HCR REDHILL SPV, LLC
To: REDHILL BIOPHARMA INC.; REDHILL BIOPHARMA LTD.
Reel/Frame 068034/0458 →